Preventive health propels biotics supplements to $6.2b by 2036

Capsules are projected to dominate the market.

The biotics supplements market is projected to reach $6.2b in 2036, as consumers prioritise preventive healthcare, gut health, immunity, and evidence-backed nutritional solutions.

In a report, Future Market Insights said supplement manufacturers and brands are now increasingly emphasising scientifically validated formulations, dosage consistency, and transparent labelling to strengthen consumer trust.

Capsules are projected to dominate the market, accounting for 40% of global demand in 2026.

The report noted that adoption is driven by dosing familiarity, manufacturing compatibility, consumer convenience, and ease of formulation.

Moreover, plant-based ingredients are expected to capture 33% of market demand as consumers increasingly seek vegan-friendly, sustainable, and clean-label products.

However, regulatory requirements on health claims, ingredient documentation, manufacturing quality, and product labelling can delay commercialisation.

On a regional basis, rapid digital commerce expansion and increasing consumer awareness support strong market growth across Asia-Pacific, with India at 7.3% compound annual growth rate, China at 6.1%, whilst South Korea and Japan at 4.7% and 3.5%, respectively.